High Quality Factory Supply Orlistat Powder CAS 96829-58-2 Weight Loss Orlistat

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Solid
• Purity: 99.9%
• Model NO.: HRK-Orlistat
• Product Name: Orlistat
• Appearance: White Powder
• Active Ingredient: Orlistat
• Sample: Orlistat Avaliable
• Einecs No: 639-755-1
• CAS No: 96829-58-2
• Mf: C17h19n3o3s
• MW: 495.73
• Certificate: GMP ISO USP Bp
• Test: HPLC
• Grade Standard: Medicine Grade
• Assay: 99.9% Min
• Storage: Cool Dry Place
• Shelf Life: 2 Years Proper Storage
• Application: Weight Loss
• Transport Package: 100 Per Bag
• Specification: 99% min
• Trademark: Henrikang
• Origin: Shaanxi China
• Production Capacity: 5000kg/Year

Product Description

High Quality Factory Supply Orlistat Powder CAS 96829-58-2 Weight Loss Orlistat

Product Name	Weight Loss Orlistat Powder CAS 96829-58-2 Orlistat Used for Lipid-lowering Drug
Appearance	White powder
Assay	99%min
Test	HPLC
Certificate	ISO 9001
CAS	96829-58-2
MF	C17H19N3O3S
Storage Temperature	Cool Dry Place

What is Orlistat Powder ?

Orlistat is a long-acting, powerful and specific gastrointestinal lipase inhibitor, which inactivates the above two
enzymes by forming covalent bonds with lipase active serine sites in the stomach and small intestine. The
inactivated enzymes cannot decompose the fats in food into free fatty acids and glycerol that can be absorbed
by the human body, thus reducing fat intake and weight loss. In addition, it has been found that orlistat inhibits
intestinal cholesterol absorption by inhibiting niemann-pickC1-like1 (NPC1L1).

Pharmacological effects of orlistat:

This product in combination with a mild low calorie diet is indicated for the long-term treatment of obese
and overweight patients, including those who have developed risk factors associated with obesity. This
product is effective for long-term weight control (weight loss, weight maintenance and weight rebound
prevention). Orlistat is associated with reduced risk factors for obesity and other obesity-related diseases,
including hypercholesterolemia, type 2 diabetes, impaired glucose tolerance, hyperinsulinemia, hypertension,
and reduced fat content in the organs.